Skip to main content

Advertisement

SpringerLink
Log in

Hemostatic abnormalities in critically ill patients

  • IM - REVIEW
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Hemostatic abnormalities frequently occur in critically ill patients and may vary from prolonged global clotting tests or isolated thrombocytopenia, to composite defects, such as consumption coagulopathies. There are many reasons for a disturbed coagulation in intensive care patients, and each of these underlying syndromes may require specific therapeutic intervention. Hence, an adequate differential diagnosis and initiation of proper (supportive) therapeutic strategies are critical to decrease morbidity and mortality in critically ill patients with hemostatic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hunt BJ (2014) Bleeding and coagulopathies in critical care. N Engl J Med 370:847–859

    Article  CAS  PubMed  Google Scholar 

  2. Levi M, Schultz M (2010) Coagulopathy and platelet disorders in critically ill patients. Minerva Anestesiol 76:851–859

    CAS  PubMed  Google Scholar 

  3. Levi M, Opal SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10:222

    Article  PubMed Central  PubMed  Google Scholar 

  4. Vanderschueren S, De Weerdt A, Malbrain M et al (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871–1876

    Article  CAS  PubMed  Google Scholar 

  5. Levi M, van der Poll T (2013) Endothelial injury in sepsis. Intensive Care Med 39:1839–1842

    Article  PubMed  Google Scholar 

  6. Ahmed A, Kojicic M, Herasevich V, Gajic O (2009) Early identification of patients with or at risk of acute lung injury. Neth J Med 67:268–271

    CAS  PubMed  Google Scholar 

  7. Schultz MJ (2009) Early recognition of critically ill patients. Neth J Med 67:266–267

    CAS  PubMed  Google Scholar 

  8. Strauss R, Wehler M, Mehler K et al (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30:1765–1771

    Article  PubMed  Google Scholar 

  9. Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS (2002) D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 121:1262–1268

    Article  PubMed  Google Scholar 

  10. Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  CAS  PubMed  Google Scholar 

  11. Dempfle CE, Borggrefe M (2008) Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 34:445–450

    Article  PubMed  Google Scholar 

  12. Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K (2010) Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 21:168–174

    Article  PubMed  Google Scholar 

  13. Park MS, Martini WZ, Dubick MA et al (2009) Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 67:266–275

    Article  PubMed Central  PubMed  Google Scholar 

  14. Collins PW, Macchiavello LI, Lewis SJ et al (2006) Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 135:220–227

    Article  PubMed  Google Scholar 

  15. Greaves M, Preston FE (2001) Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and thrombosis. Basic principles and clinical practice. Lippingcott William & Wilkins, Philadelphia, pp 1031–1043

    Google Scholar 

  16. Edmunds LH (2001) Hemostatic problems in surgical patients. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and thrombosis. Basic principles and clinical practice. Lippingcott William & Wilkins, Philadelphia, pp 1031–1043

    Google Scholar 

  17. Bailey B, Amre DK, Gaudreault P (2003) Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 31:299–305

    Article  CAS  PubMed  Google Scholar 

  18. Vlaar AP, Schultz MJ, Juffermans NP (2009) Transfusion-related acute lung injury: a change of perspective. Neth J Med 67:320–326

    CAS  PubMed  Google Scholar 

  19. Mavrommatis AC, Theodoridis T, Orfanidou A et al (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451–457

    Article  CAS  PubMed  Google Scholar 

  20. de Stoppelaar SF, van’t Veer C, van der Poll T (2014) The role of platelets in sepsis. Thromb Haemost 112:666–677

    Article  PubMed  Google Scholar 

  21. de Stoppelaar SF, van’t Veer C, Claushuis TA et al (2014) Thrombocytopenia impairs host defense in gram-negative pneumonia derived sepsis. Blood (in press)

  22. Folman CC, Linthorst GE, van Mourik J et al (2000) Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemost 83:923–930

    CAS  PubMed  Google Scholar 

  23. Francois B, Trimoreau F, Vignon P et al (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103:114–120

    Article  CAS  PubMed  Google Scholar 

  24. Levi M, Lowenberg EC (2008) Thrombocytopenia in critically ill patients. Semin Thromb Hemost 34:417–424

    Article  PubMed  Google Scholar 

  25. Eerenberg ES, Levi M (2014) The potential therapeutic benefit of targeting ADAMTS13 activity. Semin Thromb Hemost 40:28–33

    CAS  PubMed  Google Scholar 

  26. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600

    Article  CAS  PubMed  Google Scholar 

  27. Tsai HM (2003) Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 23:388–396

    Article  PubMed  Google Scholar 

  28. van den Born BJ, van der Hoeven NV, Groot E et al (2008) Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension 51:862–866

    Article  PubMed  Google Scholar 

  29. Stephan F, Hollande J, Richard O et al (1999) Thrombocytopenia in a surgical ICU. Chest 115:1363–1370

    Article  CAS  PubMed  Google Scholar 

  30. Warkentin TE, Aird WC, Rand JH (2003) Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology 14:497–519

    Article  Google Scholar 

  31. Verma AK, Levine M, Shalansky SJ, Carter CJ, Kelton JG (2003) Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 23:745–753

    Article  PubMed  Google Scholar 

  32. Warkentin TE (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535–555

    Article  CAS  PubMed  Google Scholar 

  33. Levi M, van der Poll T (2008) The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients. Semin Thromb Hemost 34:459–468

    Article  CAS  PubMed  Google Scholar 

  34. Levi M, Nieuwdorp M, van der Poll T, Stroes E (2008) Metabolic modulation of inflammation-induced activation of coagulation. Semin Thromb Hemost 34:26–32

    Article  CAS  PubMed  Google Scholar 

  35. Griffin JH, Fernandez JA, Gale AJ, Mosnier LO (2007) Activated protein C. J Thromb Haemost 5(Suppl 1):73–80

    Article  CAS  PubMed  Google Scholar 

  36. Esmon CT (2001) Role of coagulation inhibitors in inflammation. Thromb Haemost 86(1):51–56

    CAS  PubMed  Google Scholar 

  37. Levi M, de Jonge E, van der Poll T (2001) Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 29(7 Suppl):S90–S94

    Article  CAS  PubMed  Google Scholar 

  38. Esmon CT (1987) The regulation of natural anticoagulant pathways. Science 235:1348–1352

    Article  CAS  PubMed  Google Scholar 

  39. Esmon CT (2000) The endothelial cell protein C receptor. Thromb Haemost 83:639–643

    CAS  PubMed  Google Scholar 

  40. Mesters RM, Helterbrand J, Utterback BG et al (2000) Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 28:2209–2216

    Article  CAS  PubMed  Google Scholar 

  41. Vary TC, Kimball SR (1992) Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol 262:C445–C452

    CAS  PubMed  Google Scholar 

  42. Eckle I, Seitz R, Egbring R, Kolb G, Havemann K (1991) Protein C degradation in vitro by neutrophil elastase. Biol Chem Hoppe Seyler 372:1007–1013

    Article  CAS  PubMed  Google Scholar 

  43. Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740–745

    Article  CAS  PubMed  Google Scholar 

  44. Faust SN, Levin M, Harrison OB et al (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345:408–416

    Article  CAS  PubMed  Google Scholar 

  45. Taylor FBJ, Stearns-Kurosawa DJ, Kurosawa S et al (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680–1686

    CAS  PubMed  Google Scholar 

  46. Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109:2698–2704

    Article  PubMed  Google Scholar 

  47. Fuchs TA, Brill A, Wagner DD (2012) Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 32:1777–1783

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Andrews RK, Arthur JF, Gardiner EE (2014) Neutrophil extracellular traps (NETs) and the role of platelets in infection. Thromb Haemost 112:659–665

    Article  PubMed  Google Scholar 

  49. Saffarzadeh M, Juenemann C, Queisser MA et al (2012) Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 7:e32366

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Kowalska MA, Zhao G, Zhai L et al (2013) Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation. Arterioscler Thromb Vasc Biol 34(1):120–126

    Article  PubMed  Google Scholar 

  51. Wildhagen KC, de Garcia FP, Reutelingsperger CP et al (2013) Non-anticoagulant heparin prevents histone-mediated cytotoxicity and improves survival in sepsis. Blood 123(7):1098–1101

    Article  PubMed  Google Scholar 

  52. Levi M (2014) The dual face of heparin in severe infection. Blood 123:947–948

    Article  CAS  PubMed  Google Scholar 

  53. Levi M, van der Poll T (2014) A short contemporary history of disseminated intravascular coagulation. Semin Thromb Hemost 40:874–880

    Article  PubMed  Google Scholar 

  54. Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341:586–592

    Article  CAS  PubMed  Google Scholar 

  55. Levi M (2014) Diagnosis and treatment of disseminated intravascular coagulation. Int J Lab Hematol 36:228–236

    Article  CAS  PubMed  Google Scholar 

  56. Levi M (2014) Cancer-related coagulopathies. Thromb Res 133(Suppl 2):S70–S75

    Article  CAS  PubMed  Google Scholar 

  57. Levi M, Schultz M, van der Poll T (2013) Sepsis and thrombosis. Semin Thromb Hemost 39:559–566

    Article  CAS  PubMed  Google Scholar 

  58. Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214

    Article  CAS  PubMed  Google Scholar 

  59. Levi M, Schouten M, van der Poll T (2008) Sepsis, coagulation, and antithrombin: old lessons and new insights. Semin Thromb Hemost 34:742–746

    Article  CAS  PubMed  Google Scholar 

  60. Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the management of disseminated intravascular coagulation. Br J Haematol 145:24–33

    Article  CAS  PubMed  Google Scholar 

  61. Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330

    CAS  PubMed  Google Scholar 

  62. Dhainaut JF, Yan SB, Joyce DE et al (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924–1933

    Article  CAS  PubMed  Google Scholar 

  63. Wada H, Gabazza EC, Asakura H et al (2003) Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 74:17–22

    Article  PubMed  Google Scholar 

  64. Gando S, Saitoh D, Ogura H et al (2013) A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 17:R111

    Article  PubMed Central  PubMed  Google Scholar 

  65. Levi M (2013) Another step in improving the diagnosis of disseminated intravascular coagulation in sepsis. Crit Care 17:448

    Article  PubMed Central  PubMed  Google Scholar 

  66. Chitlur M, Rivard GE, Lillicrap D et al (2014) Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 12:103–106

    Article  CAS  PubMed  Google Scholar 

  67. Haase N, Ostrowski SR, Wetterslev J et al (2014) Thromboelastography in patients with severe sepsis: a prospective cohort study. Intensive Care Med (in press)

  68. Ranucci M, Baryshnikova E, Colella D (2012) Monitoring prohemostatic treatment in bleeding patients. Semin Thromb Hemost 38:282–291

    Article  CAS  PubMed  Google Scholar 

  69. Spahn DR, Bouillon B, Cerny V et al (2013) Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 17:R76

    Article  PubMed Central  PubMed  Google Scholar 

  70. Hellstern P, Muntean W, Schramm W, Seifried E, Solheim B (2002) Practical guidelines for the clinical use of plasma. Thromb Res 107(Suppl 1):S53

    Article  CAS  PubMed  Google Scholar 

  71. Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 164:361–369

    Article  CAS  PubMed  Google Scholar 

  72. Mannucci PM, Levi M (2007) Prevention and treatment of major blood loss. N Engl J Med 356:2301–2311

    Article  CAS  PubMed  Google Scholar 

  73. Henry DA, Carless PA, Moxey AJ et al (2011) Anti-fibrinolytic use for minimising perioperative blood transfusion. Cochrane Database Syst Rev 3:CD1886

  74. Mannucci PM (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90:2515–2521

    CAS  PubMed  Google Scholar 

  75. Levi M, Cromheecke ME, de Jonge E et al (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947

    Article  CAS  PubMed  Google Scholar 

  76. Porte RJ, Molenaar IQ, Begliomini B et al (2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 355(9212):1303–1309

    Article  CAS  PubMed  Google Scholar 

  77. Shakur H, Roberts I, Bautista R et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23–32

    Article  CAS  PubMed  Google Scholar 

  78. Hunt BJ (2015) The current place of tranexamic acid in the management of bleeding. Anaesthesia 70(Suppl 1):50-e18

    Google Scholar 

  79. Levi M, Levy JH, Andersen HF, Truloff D (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791–1800

    Article  CAS  PubMed  Google Scholar 

  80. Warren BL, Eid A, Singer P et al (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869–1878

    Article  CAS  PubMed  Google Scholar 

  81. Kienast J, Juers M, Wiedermann CJ et al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97

    Article  CAS  PubMed  Google Scholar 

  82. Iba T (2014) Controversies regarding the use of antithrombin for sepsis-associated disseminated intravascular coagulation: an update of the evidence. Blood Transfus (in press)

  83. Iba T, Saitoh D, Wada H, Asakura H (2014) Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey. Crit Care 18:497. doi:10.2450/2014.0164-14

    Article  PubMed Central  PubMed  Google Scholar 

  84. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H (2014) Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost 12:1470–1479

    Article  CAS  PubMed  Google Scholar 

  85. Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064

    Article  CAS  PubMed  Google Scholar 

  86. Saito H, Maruyama I, Shimazaki S et al (2007) Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5:31–41

    Article  CAS  PubMed  Google Scholar 

  87. Aikawa N, Shimazaki S, Yamamoto Y et al (2011) Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial. Shock. 35:349–354

    Article  CAS  PubMed  Google Scholar 

  88. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H (2014) Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. doi:10.1111/jth.12786

    Google Scholar 

  89. Vincent JL, Ramesh MK, Ernest D et al (2013) A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 41:2069–2079

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Marcel Levi & Suthesh Sivapalaratnam

  2. Department of Vascular Medicine/Internal Medicine, Academic Medical Centre F-4, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    Marcel Levi

Authors
  1. Marcel Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suthesh Sivapalaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcel Levi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levi, M., Sivapalaratnam, S. Hemostatic abnormalities in critically ill patients. Intern Emerg Med 10, 287–296 (2015). https://doi.org/10.1007/s11739-014-1176-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-014-1176-2

Keywords

Search

Navigation